<DOC>
	<DOCNO>NCT00433160</DOCNO>
	<brief_summary>To evaluate efficacy teriparatide base measurement bone mineral density lumbar spine</brief_summary>
	<brief_title>Phase 3 Clinical Trial Teriparatide Japan</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Japanese patient diagnosed osteoporosis Aged 55 old Patients high risk fracture History metabolic bone disorder primary osteoporosis History malignant neoplasm 5 year , exception superficial basal cell carcinoma squamous cell carcinoma skin definitively treat . Severe chronically disable condition osteoporosis</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>